Indivior Pharmaceuticals (INDV) Free Cash Flow (2022 - 2025)
Historic Free Cash Flow for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to -$59.0 million.
- Indivior Pharmaceuticals' Free Cash Flow fell 108000.0% to -$59.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.0 million, marking a year-over-year increase of 14407.41%. This contributed to the annual value of $7.0 million for FY2024, which is 10227.27% up from last year.
- As of Q3 2025, Indivior Pharmaceuticals' Free Cash Flow stood at -$59.0 million, which was down 108000.0% from $141.0 million recorded in Q2 2025.
- Over the past 5 years, Indivior Pharmaceuticals' Free Cash Flow peaked at $141.0 million during Q2 2025, and registered a low of -$310.0 million during Q4 2023.
- In the last 4 years, Indivior Pharmaceuticals' Free Cash Flow had a median value of -$9.0 million in 2023 and averaged -$11.2 million.
- In the last 5 years, Indivior Pharmaceuticals' Free Cash Flow soared by 103333.33% in 2024 and then plummeted by 108000.0% in 2025.
- Over the past 4 years, Indivior Pharmaceuticals' Free Cash Flow (Quarter) stood at -$27.0 million in 2022, then tumbled by 1048.15% to -$310.0 million in 2023, then soared by 89.35% to -$33.0 million in 2024, then plummeted by 78.79% to -$59.0 million in 2025.
- Its Free Cash Flow stands at -$59.0 million for Q3 2025, versus $141.0 million for Q2 2025 and $70.0 million for Q1 2025.